Evolv Technologies vs TransAct Technologies
EVLV and TACT side by side, both in computer and office equipment. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How EVLV and TACT compare
Evolv Technologies is the larger company, worth 15 times as much as TransAct Technologies ($753M against $50.4M).
Evolv Technologies grew revenue faster over the last twelve months (28.9% versus 10.5% for TransAct Technologies).
TransAct Technologies keeps more of each dollar of sales as profit, with a net margin of −0.75% compared with −10.8% at Evolv Technologies.
TransAct Technologies scores higher on the StockData Score (10 against 7 for Evolv Technologies), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | EVLV | TACT |
|---|---|---|
| Size and price | ||
| Market cap | $753M | $50.4M |
| Share price | $4.16 | $4.88 |
| Change, 1 year | −40.9% | 13.0% |
| Change, 5 years | −32.5% | −56.4% |
| Beta (5Y) | 1.63 | 0.89 |
| Employees | 286 | 103 |
| StockData Score | ||
| Total score | 7 | 10 (better) |
| Valuation score | 0 | 1 (better) |
| Growth score | 3 (better) | 2 |
| Performance score | 1 | 1 |
| Health score | 3 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 4.3× | 1.0× (better) |
| P/B | 7.0× | 1.5× (better) |
| EV/EBITDA | – | 156× |
| P/FCF | – | 9.6× |
| FCF yield | – | 10.4% |
| Fair value | $3.92 | $4.02 |
| Margin of safety | −6.1% (better) | −21.3% |
| Growth | ||
| Revenue growth (TTM) | 28.9% (better) | 10.5% |
| Revenue growth, 5Y average | 93.5% (better) | 11.0% |
| Profitability | ||
| Gross margin | 49.9% (better) | 49.6% |
| Operating margin | −23.5% | −0.80% (better) |
| Net margin | −10.8% | −0.75% (better) |
| FCF margin | – | 9.9% |
| Return on equity | −18.1% | −1.3% (better) |
| Return on invested capital | −45.4% | −2.5% (better) |
| Financial health | ||
| Debt / equity | 0.27 (better) | 0.00 |
| Interest coverage | −10.5× | – |
| Current ratio | 1.09 | 2.65 (better) |
| Altman Z-score | 0.56 | 3.36 (better) |
| Piotroski F-score | 4 | 5 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 66.9% | 38.0% |
| Held by insiders | 11.7% | 62.0% |
| Insider net buying, 12 months | −$6.2M | $351K (better) |
| Short interest, % of float | 6.1% | 0.70% |
Go deeper
- EVLV stock overview
- EVLV income statement
- EVLV valuation and score
- TACT stock overview
- TACT income statement
- TACT valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.